Pressure Wire Assessment of Hemodynamic Alterations after Chemoembolization of Hepatocellular Carcinoma
Authors:
- Andrea FrangosAFAndrea Frangos
- Jeffrey W. McCannJMJeffrey W. McCann
- Daniel B. BrownDBDaniel B. Brown
- 1 August 2013
- journal article
- clinical trial
- Published by Elsevier in Academic Radiology
- Vol. 20 (8) , 1037-1040
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chemoembolization Endpoints: Effect on Survival Among Patients With Hepatocellular CarcinomaAmerican Journal of Roentgenology, 2011
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- Society of Interventional Radiology Position Statement on Chemoembolization of Hepatic MalignanciesJournal of Vascular and Interventional Radiology, 2009
- Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary InterventionNew England Journal of Medicine, 2009
- Effect of Transcatheter Arterial Embolization on Levels of Hypoxia-inducible Factor-1α in Rabbit VX2 Liver TumorsJournal of Vascular and Interventional Radiology, 2007
- Dutch Iliac Stent Trial: Long-term Results in Patients Randomized for Primary or Selective Stent PlacementRadiology, 2006
- A Multicentre Evaluation of the Medtronic AVE Flexible Iliac Bridge Stent in the Iliac Arteries (the First Study)European Journal of Vascular and Endovascular Surgery, 2005
- The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinomaLiver Transplantation, 2004
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002